Related Experiment Video
Updated: Jun 27, 2025
Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration
Published on: June 7, 2012
Therapeutic Potential of 4-Hexylresorcinol in Preserving Testicular Function in Streptozotocin-Induced Diabetic Rats
Ji-Hyeon Oh1, Je-Yong Choi2, Dae-Won Kim3
1Department of Oral and Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University, Gangneung 25457, Republic of Korea.
Abstract:
It is known that many diabetic patients experience testicular atrophy. This study sought to investigate the effect of 4-hexylresorcinol (4HR) on testicular function in rats with streptozotocin (STZ)-induced diabetes, focusing on testicular weight, sperm motility, histological alterations, and serum testosterone levels to understand the efficacy of 4HR on testes. Our findings reveal that 4HR treatment significantly improves testicular health in diabetic rats. Notably, the STZ group exhibited a testicular weight of 1.22 ± 0.48 g, whereas the STZ/4HR group showed a significantly enhanced weight of 1.91 ± 0.26 g (p < 0.001), aligning closely with the control group's weight of 1.99 ± 0.17 g and the 4HR group's weight of 2.05 ± 0.24 g, indicating no significant difference between control and 4HR groups (p > 0.05). Furthermore, the STZ/4HR group demonstrated significantly improved sperm motility compared to the STZ group, with apoptotic indicators notably reduced in the STZ/4HR group relative to the STZ group (p < 0.05). These results underscore the therapeutic potential of 4HR for maintaining testicular function under diabetic conditions.
Insights
4-hexylresorcinol (4HR) significantly improves testicular function in diabetic rats. Treatment with 4HR restored testicular weight and enhanced sperm motility, offering therapeutic potential for diabetic testicular atrophy.
Area of Science:
- Endocrinology
- Reproductive Biology
- Diabetology
Background:
- Diabetes mellitus is associated with testicular atrophy.
- Diabetic complications can impair male reproductive health.
- Understanding protective agents is crucial for managing diabetic complications.
Purpose of the Study:
- To investigate the protective effects of 4-hexylresorcinol (4HR) on testicular function in streptozotocin (STZ)-induced diabetic rats.
- To evaluate the impact of 4HR on testicular weight, sperm motility, histology, and serum testosterone levels.
- To assess the therapeutic potential of 4HR in mitigating diabetes-related testicular damage.
Main Methods:
- Induction of diabetes in rats using streptozotocin (STZ).
- Administration of 4-hexylresorcinol (4HR) to diabetic rats.
- Assessment of testicular weight, sperm motility, and histological alterations.
- Measurement of serum testosterone levels.
Main Results:
- STZ-induced diabetes led to a significant decrease in testicular weight.
- 4HR treatment significantly increased testicular weight in diabetic rats, comparable to control groups.
- Sperm motility was significantly improved in diabetic rats treated with 4HR.
- Apoptotic indicators in testicular tissue were reduced by 4HR treatment.
Conclusions:
- 4-hexylresorcinol (4HR) demonstrates significant efficacy in protecting testicular function against STZ-induced diabetes.
- 4HR treatment can restore testicular weight and improve sperm quality in diabetic conditions.
- 4HR shows promise as a therapeutic agent for managing testicular dysfunction associated with diabetes.
